Shauna French

Shauna holds a Bachelor of Applied Science (Honours) in Medical Science from Queensland University of Technology, Brisbane. She completed her PhD at Monash University, Melbourne, and was undertaking post-doctoral research at Harvard Medical School, Boston, prior to joining the firm.

During her academic career, Shauna specialised in investigating the cellular and molecular mechanisms of haematological disorders. She has authored over 12 peer-reviewed publications in this space. Most notably, her PhD work involved the development of novel therapeutic antibodies for the treatment of thrombosis. Shauna has broad expertise in many scientific disciplines, including: molecular and cell biology, biochemistry, genetics, nanotechnology, immunology and pharmacology. Additionally, Shauna has specialised expertise in microfluidic platforms, microvesicles and exosome biology, and therapeutic antibody development.

Throughout her career, Shauna has worked extensively with local and international industry partners, which range from Australian and international biopharmaceutical companies to US biotechnology startups. Shauna is passionate about the development of biotherapeutics and is eager to bring her scientific expertise to help clients achieve their commercialisation goals.

Shauna has completed a short course in Healthcare Innovation at Harvard Medical School and her Masters in Intellectual Property at The University of Melbourne.

Shauna won the the Edward Waters Prize in 2023, awarded by The Institute of Patent and Trade Mark Attorneys of Australia.

Shauna is a registered Australian and New Zealand patent attorney.